Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.

MLA

Siddiqui, Mariah, et al. “Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.” Cureus, vol. 13, no. 1, Jan. 2021, p. e13002. EBSCOhost, https://doi.org/10.7759/cureus.13002.

APA

Siddiqui, M., Shah, P. V., Balani, P., Lopez, A. R., Nobleza, C. M. N., & Khan, S. (2021). Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines. Cureus, 13(1), e13002. https://doi.org/10.7759/cureus.13002

Chicago

Siddiqui, Mariah, Parth V Shah, Prachi Balani, Angel R Lopez, Chelsea Mae N Nobleza, and Safeera Khan. 2021. “Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.” Cureus 13 (1): e13002. doi:10.7759/cureus.13002.